# Dapsone

NDC: 62135-965
Generic name: Dapsone
Labeler / Manufacturer: Chartwell RX, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20160510

FDA application: ANDA204074

## Active ingredients

- DAPSONE: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62135-965"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62135-965
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=93028aff-54f0-4f94-b925-a91400118294